35
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Angiotensin‐converting enzyme gene polymorphism and coronary reactivity in young men

, , , , , , , , & show all
Pages 596-603 | Received 23 Nov 2006, Accepted 11 Jan 2007, Published online: 08 Jul 2009

References

  • Weir M. R., Dzau V. J. The renin‐angiotensin‐aldosterone system: a specific target for hypertension management. Am J Hypertens 1999; 12: 205S–13S
  • Ohira N., Matsumoto T., Tamaki S., Takashima H., Tarutani Y., Yamane T., et al. Angiotensin‐converting enzyme insertion/deletion polymorphism modulates coronary release of tissue plasminogen activator in response to bradykinin. Hypertens Res 2004; 27: 39–45
  • Rigat B., Hubert C., Alhenc‐Gelas F., Cambien F., Corvol P., Soubrier F. An insertion/deletion polymorphism in the angiotensin I‐converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343–6
  • Cambien F., Poirier O., Lecerf L., Evans A., Cambou J. P., Arveiler D., et al. Deletion polymorphism in the gene for angiotensin‐converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359: 641–4
  • Agerholm‐Larsen B., Nordestgaard B. G., Tybjaerg‐Hansen A. ACE gene polymorphism in cardiovascular disease: meta‐analyses of small and large studies in whites. Arterioscler Thromb Vasc Biol 2000; 20: 484–92
  • Pitkänen O. P., Nuutila P., Raitakari O. T., Porkka K., Iida H., Nuotio I., et al. Coronary flow reserve in young men with familial combined hyperlipidemia. Circulation 1999; 99: 1678–84
  • Pitkänen O. P., Raitakari O. T., Niinikoski H., Nuutila P., Iida H., Voipio‐Pulkki L. M., et al. Coronary flow reserve is impaired in young men with familial hypercholesterolemia. J Am Coll Cardiol 1996; 28: 1705–11
  • Raitakari O. T., Pitkänen O. P., Lehtimäki T., Lahdenperä S., Iida H., Ylä‐Herttuala S., et al. In vivo low density lipoprotein oxidation relates to coronary reactivity in young men. J Am Coll Cardiol 1997; 30: 97–102
  • Juonala M., Järvisalo M. J., Mäki‐Torkko N., Kähönen M., Viikari J. S., Raitakari O. T. Risk factors identified in childhood and decreased carotid artery elasticity in adulthood: the Cardiovascular Risk in Young Finns Study. Circulation 2005; 112: 1486–93
  • Sorensen K. E., Celermajer D. S., Georgakopoulos D., Hatcher G., Betteridge D. J., Deanfield J. E. Impairment of endothelium‐dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein(a) level. J Clin Invest 1994; 93: 50–5
  • Amant C., Hamon M., Bauters C., Richard F., Helbecque N., McFadden E. P., et al. The angiotensin II type 1 receptor gene polymorphism is associated with coronary artery vasoconstriction. J Am Coll Cardiol 1997; 29: 486–90
  • Prasad A., Narayanan S., Waclawiw M. A., Epstein N., Quyyumi A. A. The insertion/deletion polymorphism of the angiotensin‐converting enzyme gene determines coronary vascular tone and nitric oxide activity. J Am Coll Cardiol 2000; 36: 1579–86
  • Mulder H. J., van Geel P. P., Schalij M. J., van Gilst W. H., Zwinderman A. H., Bruschke A. V. DD ACE gene polymorphism is associated with increased coronary artery endothelial dysfunction: the PREFACE trial. Heart 2003; 89: 557–8
  • Fan Y., Laaksonen R., Janatuinen T., Vesalainen R., Nuutila P., Koivula T., et al. Hepatic lipase gene variation is related to coronary reactivity in healthy young men. Eur J Clin Invest 2001; 31: 574–80
  • Friedewald W. T., Levy R. I. Fredrickson DS. Estimation of the concentration of low‐density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502
  • Rigat B., Hubert C., Corvol P., Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 1992; 20: 1433
  • Odawara M., Matsunuma A., Yamashita K. Mistyping frequency of the angiotensin‐converting enzyme gene polymorphism and an improved method for its avoidance. Hum Genet 1997; 100: 163–6
  • Iida H., Kanno I., Takahashi A., Miura S., Murakami M., Takahashi K., et al. Measurement of absolute myocardial blood flow with H215O and dynamic positron‐emission tomography. Strategy for quantification in relation to the partial‐volume effect. Circulation 1988; 78: 104–15
  • Iida H., Takahashi A., Tamura Y., Ono Y., Lammertsma A. A. Myocardial blood flow: comparison of oxygen‐15‐water bolus injection, slow infusion and oxygen‐15‐carbon dioxide slow inhalation. J Nucl Med 1995; 36: 78–85
  • Iida H., Rhodes C. G., de Silva R., Araujo L. I., Bloomfield P. M., Lammertsma A. A., et al. Use of the left ventricular time‐activity curve as a noninvasive input function in dynamic oxygen‐15‐water positron emission tomography. J Nucl Med 1992; 33: 1669–77
  • Pietinalho A., Furuya K., Yamaguchi E., Kawakami Y., Selroos O. The angiotensin‐converting enzyme DD gene is associated with poor prognosis in Finnish sarcoidosis patients. Eur Respir J 1999; 13: 723–6
  • Tiret L., Rigat B., Visvikis S., Breda C., Corvol P., Cambien F., et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I‐converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992; 51: 197–205
  • Butler R., Morris A. D., Burchell B., Struthers A. D. DD angiotensin‐converting enzyme gene polymorphism is associated with endothelial dysfunction in normal humans. Hypertension 1999; 33: 1164–8
  • Dayanikli F., Grambow D., Muzik O., Mosca L., Rubenfire M., Schwaiger M. Early detection of abnormal coronary flow reserve in asymptomatic men at high risk for coronary artery disease using positron emission tomography. Circulation 1994; 90: 808–17
  • Celermajer D. S., Sorensen K. E., Barley J., Jeffrey S., Carter N., Deanfield J. Angiotensin‐converting enzyme genotype is not associated with endothelial dysfunction in subjects without other coronary risk factors. Atherosclerosis 1994; 111: 121–6
  • Rossi G. P., Taddei S., Virdis A., Ghiadoni L., Albertin G., Favilla S., et al. Exclusion of the ACE D/I gene polymorphism as a determinant of endothelial dysfunction. Hypertension 2001; 37: 293–300
  • Steeds R. P., Toole L. O., Channer K. S., Morice A. H. Human vascular reactivity and polymorphisms of the angiotensin‐converting enzyme and the angiotensin type 1 receptor genes. J Vasc Res 1999; 36: 445–55; discussion 535–8
  • Perticone F., Ceravolo R., Maio R., Ventura G., Zingone A., Perrotti N., et al. Angiotensin‐converting enzyme gene polymorphism is associated with endothelium‐dependent vasodilation in never treated hypertensive patients. Hypertension 1998; 31: 900–5
  • Arcaro G., Solini A., Monauni T., Cretti A., Brunato B., Lechi A., et al. ACE genotype and endothelium‐dependent vasodilation of conduit arteries and forearm microcirculation in humans. Arterioscler Thromb Vasc Biol 2001; 21: 1313–19
  • Taniwaki H., Kawagishi T., Emoto M., Shoji T., Hosoi M., Kogawa K., et al. Association of ACE gene polymorphism with arterial stiffness in patients with type 2 diabetes. Diabetes Care 1999; 22: 1858–64
  • Trevelyan J., Needham E. W., Morris A., Mattu R. K. Comparison of the effect of enalapril and losartan in conjunction with surgical coronary revascularisation versus revascularisation alone on systemic endothelial function. Heart 2005; 91: 1053–7

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.